Gene scissors find target for testicular cancer therapy
Bonn researchers uncover contribution of protein degradation processes to cisplatin resistance in germ cell tumors Cisplatin is used successfully in the chemotherapy of testicular cancer. However, patients who develop resistance to the cytostatic drug urgently need alternative therapy options. Researchers at the University Hospital Bonn (UKB) have now been able to elucidate a mechanism underlying…